Valiant Organics Limited (VALIANTORG) AI Stock Analysis

• Market Cap: ₹9.33B
• Dividend Yield: N/A
• Average Volume (3M): 2.40K
• Price to Earnings (P/E): 180.6
• Beta (1Y): 0.76
• Revenue Growth: 9.59%
• EPS Growth: N/A
• Country: IN
• Employees: 1,073
• Sector: Basic Materials
• Sector Strength: 58
• Industry: Chemicals
• EPS (TTM): 2.98
• Shares Outstanding: 28,004,610
• 10 Day Avg. Volume: 1,426
• 30 Day Avg. Volume: 2,396
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ₹351.00
• Price Target Upside: 5.37% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 0

• Rating: 46 Neutral
• Price Target: ₹351.00 ▲(5.37% Upside)

Valiant Organics Limited's overall stock score is primarily impacted by its weak financial performance, characterized by declining revenue, profitability issues, and inconsistent cash flows. The technical analysis suggests a bearish trend, though there is some potential for upward momentum. The high P/E ratio indicates overvaluation, further weighing down the score. The absence of earnings call data and corporate events means these factors do not influence the score.

Valiant Organics Limited Business Overview & Revenue Model

Company Description

Valiant Organics Limited (VALIANTORG) is an Indian chemical manufacturing company specializing in the production of specialty chemicals and intermediates. The company serves various industries, including pharmaceuticals, agrochemicals, and dyes, providing a diverse range of products that are integral to the manufacturing processes of these sectors. With a focus on innovation and sustainable practices, Valiant Organics has established a strong presence in both domestic and international markets.

How the Company Makes Money

Valiant Organics Limited generates revenue primarily through the manufacturing and sale of specialty chemicals and intermediates. The company's key revenue streams include the sale of products to the pharmaceutical industry for active pharmaceutical ingredient (API) production, the agrochemical sector for pesticide and fertilizer manufacturing, and the dyes industry for colorants. Valiant Organics benefits from strategic partnerships and long-term contracts with major industry players, which help ensure a steady demand for its products. Additionally, the company invests in research and development to innovate and expand its product offerings, thereby enhancing its competitive edge and market reach.

Valiant Organics Limited Financial Statement Overview

Summary

Valiant Organics Limited faces challenges with declining revenue and profitability, as well as inconsistent cash flow generation. While the balance sheet reflects a reasonable equity position, the high leverage and declining equity trend are concerning. The company needs to focus on improving profitability and stabilizing cash flows to enhance its financial health.

Income Statement

Valiant Organics Limited has experienced declining revenue over the past few years, with a significant decrease in net income from positive to negative territory. The company shows a negative net profit margin, indicating profitability issues. The gross profit margin has improved recently, but overall profitability remains weak with negative EBIT and EBITDA margins in the latest period.

Balance Sheet

The balance sheet presents a reasonable equity ratio, suggesting a solid asset base relative to liabilities. However, the debt-to-equity ratio indicates significant leverage, which poses potential financial risk. While stockholders' equity exceeds total debt, the declining trend in equity raises concerns about balance sheet robustness.

Cash Flow

The company shows a declining trend in operating cash flow, and free cash flow has been inconsistent, with recent periods showing a decrease. The free cash flow to net income ratio is concerning due to negative net income. Although there is some positive operating cash flow, the overall cash flow position is weak, with potential liquidity challenges.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	7.19B	7.19B	7.23B	10.52B	11.53B	7.55B
Gross Profit	2.42B	2.62B	470.01M	1.81B	2.17B	2.19B
EBITDA	607.48M	615.51M	425.75M	1.77B	2.12B	2.11B
Net Income	-37.36M	-37.36M	-83.91M	881.21M	1.13B	1.15B
Balance Sheet
Total Assets	11.83B	11.83B	12.48B	12.39B	11.92B	8.76B
Cash, Cash Equivalents and Short-Term Investments	131.53M	131.53M	71.02M	456.71M	499.47M	349.85M
Total Debt	2.49B	2.49B	2.57B	2.74B	3.63B	2.09B
Total Liabilities	4.58B	4.58B	5.19B	4.99B	5.43B	3.68B
Stockholders Equity	7.25B	7.25B	7.29B	6.89B	6.13B	5.02B
Cash Flow
Free Cash Flow	0.00	256.03M	90.70M	862.19M	-1.53B	-562.54M
Operating Cash Flow	0.00	564.32M	840.00M	2.38B	-307.47M	1.15B
Investing Cash Flow	0.00	-209.61M	-649.88M	-1.43B	-1.24B	-1.59B
Financing Cash Flow	0.00	-318.13M	-231.19M	-1.12B	1.67B	486.70M

Valiant Organics Limited Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 333.10
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:VALIANTORG, the sentiment is Negative. The current price of 333.1 is below the 20-day moving average (MA) of 359.19, below the 50-day MA of 361.02, and below the 200-day MA of 344.28, indicating a bearish trend. The MACD of -3.81 indicates Positive momentum. The RSI at 36.36 is Neutral, neither overbought nor oversold. The STOCH value of 9.19 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:VALIANTORG.

Valiant Organics Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
BHARATWIRE	70 Outperform	10.81B	15.41	9.83%	―	5.12%	-23.21%
DECCANCE	64 Neutral	15.22B	75.85	1.04%	0.06%	-35.17%	-22.63%
EVERESTIND	60 Neutral	10.78B	-60.13	-0.60%	0.37%	5.43%	-209.44%
FAIRCHEMOR	54 Neutral	10.13B	109.00	7.28%	0.96%	-19.46%	-80.73%
HERANBA	48 Neutral	11.90B	387.71	0.37%	0.34%	―	―
VALIANTORG	46 Neutral	₹9.33B	180.62	―	―	9.59%	―
Sector *	61 Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%

Valiant Organics Limited Corporate Events

Valiant Organics Faces Income Tax Penalty, Plans Appeal

Valiant Organics Limited has been penalized by the Ministry of Finance and Income Tax Department with a fine of Rs. 87,92,592 for the Assessment Year 2020-21 under section 271AAB of the Income Tax Act, 1961. The company plans to appeal the penalty and has requested that the proceedings be kept in abeyance until the appeal is resolved. The penalty is not expected to impact the company’s operations or other activities.